iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3032% below fair value

$0.66−0.04 (-5.43%)

Close on Nov 13, 2026Market cap $1.66MP/E –Yield –

iSpecimen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

iSpecimen's revenue for the twelve months ending Jun 30, 2026 was $466.30K, down 92.1% year over year. For fiscal 2025 it was $1.93M, down 79.2% from the year before. The highest annual figure on record is $11.14M in fiscal 2021.

Annual revenue

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$1.93M	-79.2%
FY2024	Dec 31, 2024	$9.29M	-6.4%
FY2023	Dec 31, 2023	$9.93M	-4.6%
FY2022	Dec 31, 2022	$10.40M	-6.6%
FY2021	Dec 31, 2021	$11.14M	+36.1%
FY2020	Dec 31, 2020	$8.18M	–

Quarterly revenue

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$151.94K	-78.7%
Q1 FY2026	Mar 31, 2026	$156.01K	-85.2%
Q4 FY2025	Dec 31, 2025	$51.76K	-96.5%
Q3 FY2025	Sep 30, 2025	$106.59K	-96.0%
Q2 FY2025	Jun 30, 2025	$713.14K	-75.1%
Q1 FY2025	Mar 31, 2025	$1.06M	-53.8%
Q4 FY2024	Dec 31, 2024	$1.48M	-42.7%
Q3 FY2024	Sep 30, 2024	$2.66M	-4.2%
Q2 FY2024	Jun 30, 2024	$2.86M	+76.2%
Q1 FY2024	Mar 31, 2024	$2.29M	-22.4%
Q4 FY2023	Dec 31, 2023	$2.58M	-13.0%
Q3 FY2023	Sep 30, 2023	$2.78M	+7.5%
Q2 FY2023	Jun 30, 2023	$1.63M	-30.5%
Q1 FY2023	Mar 31, 2023	$2.95M	+17.1%
Q4 FY2022	Dec 31, 2022	$2.96M	+16.2%
Q3 FY2022	Sep 30, 2022	$2.58M	-5.0%
Q2 FY2022	Jun 30, 2022	$2.34M	-19.5%
Q1 FY2022	Mar 31, 2022	$2.52M	-15.0%
Q4 FY2021	Dec 31, 2021	$2.55M	-6.2%
Q3 FY2021	Sep 30, 2021	$2.72M	+20.8%
Q2 FY2021	Jun 30, 2021	$2.90M	+93.0%
Q1 FY2021	Mar 31, 2021	$2.96M	–
Q4 FY2020	Dec 31, 2020	$2.72M	–
Q3 FY2020	Sep 30, 2020	$2.25M	–
Q2 FY2020	Jun 30, 2020	$1.50M	–